✦ LIBER ✦

Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study

✍ Scribed by J Young; AU Scherrer; HF Günthard; M Opravil; S Yerly; J Böni; M Rickenbach; CA Fux; M Cavassini; E Bernasconi; P Vernazza; B Hirschel; M Battegay; HC Bucher; for the Swiss HIV Cohort Study

Book ID: 111063779
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 107 KB
Volume: 12
Category: Article
ISSN: 1464-2662
DOI: 10.1111/j.1468-1293.2010.00885.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of risk factors for cardiovas

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

✍ TR Glass; C Ungsedhapand; M Wolbers; R Weber; PL Vernazza; M Rickenbach; H Furre 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

A cohort study of treatment-experienced

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure

✍ Marcelin, Anne-Geneviève; Delaugerre, Constance; Beaudoux, Céline; Descamps, Dia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Early HIV viral load determination after

Early HIV viral load determination after initiating first-line antiretroviral therapy for indentifying patients with high risk of developing virological failure: data from a cohort study in a resource-limited setting

✍ Gerardo Alvarez-Uria; Praveen Kumar Naik; Rhagavakalyan Pakam; Manoranjan Midde 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

Pilot Study of Interferon-α with and wit

Pilot Study of Interferon-α with and without Amantadine for the Treatment of Hepatitis C in HIV Co-infected Individuals on Antiretroviral Therapy

✍ H. Sax; A. Friedl; E. Renner; M.H. Steuerwald; R. Weber; for the Swiss HIV Cohor 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

The associations between age and the dev

The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy

✍ CA Sabin; CJ Smith; V Delpech; J Anderson; L Bansi; R Gilson; A Schwenk; C Leen; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB